VIVIMEDLAB.NSVIVIMEDLAB.NSNSE
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -26.37% | -11.94% | -33.67% | -27.18% | -16.79% |
| Gross Profit Growth | -15.70% | +221.05% | -100.67% | -3.56% | -14.26% |
| EBITDA Growth | +0.00% | -14.41% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -287.52% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -206.42% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -206.35% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -206.35% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.01% | +0.31% | +0.12% | +0.45% | +0.06% |
| Weighted Average Shares Diluted Growth | +0.01% | +0.31% | +0.12% | +0.45% | +0.06% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -87.78% | +0.00% | +192.21% | +0.00% | +258.67% |
| Inventory Growth | +10.75% | +0.00% | -8.28% | +0.00% | -13.09% |
| Asset Growth | -22.04% | +0.00% | -3.16% | +0.00% | -2.05% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +17.76% | +0.00% | -0.65% | +0.00% | +2.01% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -35.42% | -15.88% | -12.81% | -100.00% | -100.00% |